Median R2’ was significantly higher in EGFR-amplified than non-amplified gliomas (Figure 6b; 6.36 ± 1.52 s−1 vs. 5.41 ± 1.12 s−1, p = 0.024). Here, EGFR is linked to central nervous system cancer.